Cargando…
Development and validation of a nomogram to predict recurrence and melanoma‐specific mortality in patients with negative sentinel lymph nodes
BACKGROUND: Patients with melanoma and negative sentinel nodes (SNs) have varying outcomes, dependent on several prognostic factors. Considering all these factors in a prediction model might aid in identifying patients who could benefit from a personalized treatment strategy. The objective was to co...
Autores principales: | Verver, D., van Klaveren, D., Franke, V., van Akkooi, A. C. J., Rutkowski, P., Keilholz, U., Eggermont, A. M. M., Nijsten, T., Grünhagen, D. J., Verhoef, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585628/ https://www.ncbi.nlm.nih.gov/pubmed/30307046 http://dx.doi.org/10.1002/bjs.10995 |
Ejemplares similares
-
Cutaneous Melanoma and Sentinel Lymph Node Biopsy
por: van Akkooi, A. C. J., et al.
Publicado: (2008) -
Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma
por: Mulder, E.E.A.P., et al.
Publicado: (2020) -
Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin
por: Verver, D., et al.
Publicado: (2017) -
Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population‐based study
por: Verver, D, et al.
Publicado: (2019) -
Gamma probe and ultrasound-guided fine needle aspiration cytology of the sentinel node (GULF) trial
por: Verver, Daniëlle, et al.
Publicado: (2018)